Q3 share repurchases of over $300m and the stock is nowhere! Attempt to compensate for vacationing doctors?
No dividends, as there are Sr management stock options to pay off, FDA audits to pay for, and mounting legal fees with the increased law suits being filed.
If earning is good then it will reverse the trend. Funds use TA to make decision when to buy a stock. Breaking above the range triggers the buys.